Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus

AIMS: Interferon‐free direct‐acting antiviral agent (DAA) regimens for chronic hepatitis C virus (HCV) patients have improved their health‐related quality of life (HRQOL). Currently, there are no published data assessing the impact of DAAs regimens without sofosbuvir on HRQOL. The aim of this study...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JGH Open
Hlavní autoři: Ikeda, Hiroki, Watanabe, Tsunamasa, Matsumoto, Nobuyuki, Hiraishi, Tetsuya, Nakano, Hiroyasu, Noguchi, Yohei, Hattori, Nobuhiro, Shigefuku, Ryuta, Yamashita, Masaki, Nakahara, Kazunari, Matsunaga, Kotaro, Okuse, Chiaki, Yotsuyanagi, Hiroshi, Tanaka, Atsushi, Suzuki, Michihiro, Itoh, Fumio
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley Publishing Asia Pty Ltd 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207024/
https://ncbi.nlm.nih.gov/pubmed/30483569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12052
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky